Orthofix Medical (OFIX) Share-based Compensation (2010 - 2026)

Orthofix Medical has disclosed Share-based Compensation across 16 years of filings, most recently posting $6.5 million for Q1 2026.

• Quarterly Share-based Compensation rose 0.99% year-over-year to $6.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $28.8 million (down 4.55% YoY) and the FY2025 annual result came in at $28.7 million, down 11.61% from the prior year.
• Share-based Compensation slipped to $6.5 million in Q1 2026, from $7.2 million in the prior quarter.
• Over five years, Share-based Compensation peaked at $13.2 million in Q2 2023 and troughed at $3.2 million in Q4 2023.
• A 5-year average of $7.2 million and a median of $6.5 million in 2026 frame the typical range for Share-based Compensation.
• Biggest YoY gain for Share-based Compensation was 200.55% in 2023; the steepest drop was 35.66% in 2023.
• Tracing OFIX's Share-based Compensation over 5 years: stood at $4.9 million in 2022, then sank by 35.66% to $3.2 million in 2023, then soared by 126.24% to $7.2 million in 2024, then grew by 0.68% to $7.2 million in 2025, then retreated by 9.44% to $6.5 million in 2026.
• Business Quant data shows OFIX's Share-based Compensation at $6.5 million in Q1 2026, $7.2 million in Q4 2025, and $7.2 million in Q3 2025.